Submit a Biologics License Application for CAP-1002
Delivered by the deadline
AI-confirmed · human review in progress Independent AI checks agreed on primary SEC or regulator evidence. Records are now being reviewed by hand, starting with those our customers order.
- Announced
- 29 Sep 2023
- Due
- 31 Dec 2025
- Delivered
- by 31 Dec 2024
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“Capricor plans to submit a BLA for CAP-1002 in 2025”
What we found
Evidence strength A What the grades mean
The company submitted its Biologics License Application for Deramiocel (formerly CAP-1002) in late 2024, which is prior to the 2025 deadline.
-
A Capricor Therapeutics, Inc. 10-K filed 2026-03-17
“In late 2024, we completed our submission of a BLA to the FDA seeking approval of Deramiocel for the treatment of Duchenne muscular dystrophy.” ✓ confirmed on the page
Market reaction: the shares moved +3.4% against the S&P 500 over the three sessions around the disclosure (16 Mar 2026 to 19 Mar 2026). What this measures
Checked 1 Oct 2026.
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Regulatory submission
- Indicative materiality
- High rules
- Action
- Submit
- Deliverable
- Biologics License Application for CAP-1002
- Language
- Expected (“expects”, “plans”)
- In the company’s control
- High
- Specificity
- High
- Depends on
- Regulatory
How this entry was checked
- Commitment recordedThe company's words were matched word for word against the filing.
- First checkAn AI model, Gemini (Google), read the company's later filings and recorded the outcome with a quoted passage.
- Second check: agreesA different AI model, Claude (Anthropic), re-read the evidence without being told the outcome and reached the same answer.
Confirmed. This outcome counts towards the company's Kept Score. How verification works
Are you Capricor Therapeutics, Inc.? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2023-CAPR-002534 · Corrections policy